Saturday 17 October 2026
Export RMD’s income statement to Excel — free account
ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
238.97
3.26
−1.35%
Follow RMD
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 8 | 5 | 3 | 5 | 5 | 7 | 6 | 5 | 6 |
P/E ratio |
18.63 | 27.02 | 26.94 | 35.76 | 39.33 | 75.39 | 44.55 | 43.73 | 46.75 | 32.18 |
Altman Z-Score |
10.00 | 13.01 | 10.99 | 9.69 | 13.22 | 14.05 | 10.29 | 7.25 | 11.50 | 6.76 |
P/S ratio |
5.02 | 7.36 | 5.87 | 7.59 | 8.56 | 11.21 | 9.37 | 6.79 | 6.33 | 5.33 |
Altman Z″-Score (non-manufacturers) |
9.10 | 8.65 | 7.58 | 6.40 | 7.26 | 5.97 | 5.77 | 4.89 | 7.11 | 6.79 |
P/FCF ratio |
17.41 | 22.93 | 21.37 | 57.34 | 156.94 | 57.79 | 39.80 | 46.40 | 34.17 | 32.13 |
P/Operating CF |
62.38 | 70.26 | 62.45 | 135.06 | 385.22 | 158.14 | 83.91 | 124.89 | 114.48 | 78.45 |
Beneish M-Score |
(2.59) | (2.61) | (2.48) | (2.14) | (2.10) | (2.42) | (2.73) | (2.63) | (2.45) | (2.44) |
Dividend Safety Score |
96 | — | — | — | — | — | — | — | — | — |
P/B ratio |
4.31 | 6.34 | 5.65 | 7.76 | 9.11 | 12.41 | 11.10 | 8.55 | 7.20 | 5.62 |
Price to Tangible BV |
8.80 | 15.41 | 17.89 | 39.72 | 28.39 | 63.38 | 174.81 | 0.00 | 19.12 | 17.37 |
EV/Sales |
4.83 | 7.25 | 5.96 | 7.88 | 8.69 | 11.31 | 9.61 | 7.22 | 6.37 | 5.45 |
EV/EBITDA |
12.81 | 19.42 | 18.19 | 25.03 | 26.05 | 33.03 | 28.67 | 25.78 | 22.51 | 20.94 |
EV/Operating CF |
15.11 | 21.30 | 19.94 | 47.99 | 88.60 | 49.10 | 35.42 | 41.00 | 29.50 | 27.21 |
EV/FCF |
16.76 | 22.59 | 21.72 | 59.49 | 159.46 | 58.35 | 40.81 | 49.31 | 34.36 | 32.88 |
Quick Ratio |
1.80 | 2.11 | 1.18 | 1.23 | 1.23 | 1.00 | 1.56 | 1.22 | 1.32 | 3.53 |
Current Ratio |
3.10 | 3.44 | 2.59 | 3.12 | 2.80 | 1.73 | 2.53 | 2.06 | 2.08 | 4.57 |
Net Debt/EBITDA |
(0.50) | (0.29) | 0.30 | 0.91 | 0.41 | 0.32 | 0.71 | 1.52 | 0.12 | 0.48 |
Debt/Assets |
4.45% | 8.05% | 10.15% | 21.20% | 15.02% | 13.61% | 25.38% | 30.65% | 8.81% | 31.10% |
Debt/Equity |
0.06 | 0.11 | 0.14 | 0.35 | 0.23 | 0.22 | 0.47 | 0.61 | 0.13 | 0.55 |
Asset Turnover |
0.66 | 0.68 | 0.69 | 0.71 | 0.73 | 0.69 | 0.68 | 0.73 | 0.72 | 0.61 |
Operating CF/Net income |
1.19 | 1.25 | 1.37 | 0.77 | 0.45 | 1.55 | 1.29 | 1.13 | 1.60 | 1.21 |
Capex/Depreciation |
(0.73) | (0.43) | (0.53) | (0.68) | (0.80) | (0.61) | (0.58) | (0.51) | (0.60) | (0.64) |
Interest Coverage |
(37.80) | (409.67) | 28.88 | 23.89 | 44.83 | 38.25 | 20.57 | 16.02 | 19.11 | 15.08 |
| 24.27% | 25.86% | 22.70% | 23.96% | 24.96% | 17.63% | 27.21% | 19.59% | 15.70% | 18.73% | |
| 17.77% | 18.62% | 14.99% | 15.15% | 15.87% | 10.19% | 14.30% | 11.28% | 9.66% | 10.18% | |
ROIC |
21.38% | 19.45% | 15.50% | 13.26% | 16.23% | 17.47% | 15.82% | 11.37% | 15.82% | 12.00% |
Return on Tangible Assets |
43.38% | 46.12% | 51.17% | 41.80% | 44.79% | 42.12% | 46.46% | 41.42% | 33.54% | 20.40% |
Average Days of Receivables |
66.90 | 66.63 | 65.23 | 60.93 | 58.75 | 70.14 | 58.59 | 74.00 | 75.44 | 79.57 |
Research and Development Expense of Revenue |
6.69% | 6.44% | 6.56% | 6.81% | 7.09% | 7.05% | 6.83% | 6.93% | 6.63% | 6.99% |
Selling, General and Administrative Expense of Revenue |
19.80% | 19.30% | 19.57% | 20.70% | 20.61% | 20.97% | 22.88% | 24.75% | 25.65% | 26.80% |
Intangible Assets out of Total Assets |
0.38 | 0.43 | 0.48 | 0.49 | 0.45 | 0.49 | 0.51 | 0.58 | 0.42 | 0.38 |
Share Based Compensation of Revenue |
1.85% | 1.78% | 1.71% | 1.68% | 1.82% | 2.00% | 1.95% | 2.00% | 2.07% | 2.22% |
Graham Net Nets |
0.07 | 0.03 | 0.01 | (0.01) | 0.01 | (0.01) | (0.02) | (0.05) | 0.00 | 0.01 |
Graham Number |
103.20 | 93.49 | 71.88 | 62.20 | 52.53 | 38.22 | 40.96 | 30.36 | 26.84 | 27.48 |
Earnings Yield |
5.37% | 3.70% | 3.71% | 2.80% | 2.54% | 1.33% | 2.24% | 2.29% | 2.14% | 3.11% |
Free Cash Flow Yield |
5.74% | 4.36% | 4.68% | 1.74% | 0.64% | 1.73% | 2.51% | 2.16% | 2.93% | 3.11% |
Revenue per Share |
38.85 | 35.08 | 31.87 | 28.77 | 24.50 | 22.00 | 20.49 | 18.21 | 16.39 | 14.62 |
Operating CF per Share |
12.41 | 11.94 | 9.53 | 4.72 | 2.40 | 5.07 | 5.56 | 3.21 | 3.54 | 2.93 |
Capex per Share |
(1.22) | (0.69) | (0.78) | (0.91) | (1.07) | (0.80) | (0.73) | (0.54) | (0.50) | (0.51) |
Free Cash Flow per Share |
11.19 | 11.25 | 8.75 | 3.81 | 1.34 | 4.27 | 4.82 | 2.67 | 3.04 | 2.42 |
Cash per Share |
10.10 | 8.24 | 1.62 | 1.55 | 1.87 | 2.03 | 3.21 | 1.03 | 1.32 | 5.81 |
Shareholders Equity per Share |
45.25 | 40.68 | 33.08 | 28.14 | 23.01 | 19.86 | 17.30 | 14.48 | 14.42 | 13.87 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
45.25 | 40.68 | 33.08 | 28.14 | 23.01 | 19.86 | 17.30 | 14.48 | 14.42 | 13.87 |
Free Cash Flow |
1,628.66 | 1,650.95 | 1,286.40 | 559.30 | 195.11 | 619.89 | 696.32 | 381.71 | 433.57 | 342.58 |
Working Capital |
2,929.63 | 2,486.49 | 1,447.06 | 1,609.30 | 1,242.18 | 662.99 | 920.70 | 589.38 | 554.47 | 1,283.88 |
Capital Expenditures |
(177.17) | (100.64) | (114.86) | (134.00) | (156.04) | (116.83) | (105.94) | (77.34) | (71.46) | (71.48) |
Net Current Asset Value |
1,944.18 | 1,299.07 | 349.37 | (253.97) | 196.38 | (267.69) | (566.89) | (890.12) | 60.77 | 135.78 |
EV/EBIT |
14.46 | 22.13 | 21.17 | 29.40 | 31.10 | 40.03 | 35.09 | 32.50 | 27.49 | 26.45 |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
Price to Operating Income |
15.03 | 22.46 | 20.82 | 28.33 | 30.61 | 39.64 | 34.23 | 30.58 | 27.34 | 25.85 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.42 | 0.43 | 0.39 | 0.37 | 0.39 | 0.41 | 0.43 | 0.39 | 0.31 | 0.28 |
Cash ROIC |
19.26% | 21.07% | 22.18% | 9.66% | 4.43% | 16.21% | 16.88% | 10.97% | 17.22% | 8.87% |
Accounts Receivable Turnover |
5.72 | 5.79 | 6.08 | 6.59 | 6.01 | 5.87 | 5.90 | 5.15 | 5.01 | 4.96 |
Accounts Payable Turnover |
7.50 | 8.11 | 10.45 | 12.05 | 10.45 | 9.92 | 9.85 | 10.67 | 10.84 | 9.33 |
Inventory Turnover |
2.35 | 2.39 | 2.23 | 2.14 | 2.59 | 3.11 | 3.23 | 3.60 | 3.74 | 3.51 |
Average Days of Payables |
51.21 | 48.55 | 42.74 | 29.47 | 37.41 | 37.10 | 39.99 | 37.97 | 33.67 | 39.14 |
Days of Inventory on Hand |
156.80 | 161.91 | 147.84 | 195.08 | 174.75 | 122.87 | 122.80 | 114.71 | 97.56 | 113.22 |
Average Receivables |
987.86 | 888.38 | 771.09 | 640.43 | 595.12 | 544.47 | 501.56 | 506.08 | 467.11 | 416.31 |
Average Payables |
293.54 | 257.94 | 194.24 | 155.00 | 148.63 | 136.90 | 125.76 | 104.22 | 92.74 | 92.67 |
Average Inventory |
936.76 | 874.98 | 910.13 | 870.96 | 600.47 | 436.97 | 383.28 | 309.17 | 268.51 | 246.39 |
Average Assets |
8,570.17 | 7,523.39 | 6,812.05 | 5,923.78 | 4,911.99 | 4,657.75 | 4,347.53 | 3,585.80 | 3,266.21 | 3,362.60 |
Average Common Equity |
6,276.63 | 5,415.95 | 4,496.97 | 3,745.33 | 3,123.22 | 2,691.35 | 2,284.61 | 2,065.59 | 2,009.62 | 1,827.55 |
Columns are period end dates